ID   VNN1_HUMAN              Reviewed;         513 AA.
AC   O95497; A8K310; Q4JFW6; Q4VAS7; Q4VAS8; Q4VAS9; Q9UF16; Q9UJF4;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Pantetheinase;
DE            EC=3.5.1.92 {ECO:0000269|PubMed:11491533, ECO:0000269|PubMed:25478849};
DE   AltName: Full=Pantetheine hydrolase;
DE   AltName: Full=Tiff66;
DE   AltName: Full=Vascular non-inflammatory molecule 1;
DE            Short=Vanin-1;
DE   Flags: Precursor;
GN   Name=VNN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-26.
RC   TISSUE=Liver;
RX   PubMed=9790769; DOI=10.1006/geno.1998.5481;
RA   Galland F., Malergue F., Bazin H., Mattei M.-G., Aurrand-Lions M.,
RA   Theillet C., Naquet P.;
RT   "Two human genes related to murine vanin-1 are located on the long arm
RT   of human chromosome 6.";
RL   Genomics 53:203-213(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ILE-26.
RA   Prehn S., Friedrichson T., Henske A., Boehm S., Hartmann E.,
RA   Kurzchalia T.V.;
RT   "Human Tiff66.";
RL   Submitted (OCT-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-26.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-26; THR-63;
RP   SER-131; LEU-136; ASN-146; ASP-296; GLU-325; ALA-336 AND THR-373.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-131.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=10567687; DOI=10.1016/S0014-5793(99)01439-8;
RA   Maras B., Barra D., Dupre S., Pitari G.;
RT   "Is pantetheinase the actual identity of mouse and human vanin-1
RT   proteins?";
RL   FEBS Lett. 461:149-152(1999).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11491533; DOI=10.1007/s002510100327;
RA   Martin F., Malergue F., Pitari G., Philippe J.M., Philips S.,
RA   Chabret C., Granjeaud S., Mattei M.G., Mungall A.J., Naquet P.,
RA   Galland F.;
RT   "Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode
RT   isoforms of pantetheinase ectoenzymes.";
RL   Immunogenetics 53:296-306(2001).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-38 AND ASN-353.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.M400015-MCP200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,
RA   Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-130; ASN-283; ASN-315 AND
RP   ASN-353.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION BY CYTOKINES.
RX   PubMed=19322213; DOI=10.1038/jid.2009.67;
RA   Jansen P.A.M., Kamsteeg M., Rodijk-Olthuis D.,
RA   van Vlijmen-Willems I.M.J.J., de Jongh G.J., Bergers M.,
RA   Tjabringa G.S., Zeeuwen P.L.J.M., Schalkwijk J.;
RT   "Expression of the vanin gene family in normal and inflamed human
RT   skin: induction by proinflammatory cytokines.";
RL   J. Invest. Dermatol. 129:2167-2174(2009).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-353.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 22-513 IN COMPLEX WITH
RP   SYNTHETIC INHIBITOR, FUNCTION, CATALYTIC ACTIVITY, GLYCOSYLATION AT
RP   ASN-38; ASN-130; ASN-200; ASN-315 AND ASN-353, ACTIVE SITE, SUBUNIT,
RP   AND MUTAGENESIS OF GLU-79 AND LYS-178.
RX   PubMed=25478849; DOI=10.1107/S1399004714022767;
RA   Boersma Y.L., Newman J., Adams T.E., Cowieson N., Krippner G.,
RA   Bozaoglu K., Peat T.S.;
RT   "The structure of vanin 1: a key enzyme linking metabolic disease and
RT   inflammation.";
RL   Acta Crystallogr. D 70:3320-3329(2014).
CC   -!- FUNCTION: Amidohydrolase that hydrolyzes specifically one of the
CC       carboamide linkages in D-pantetheine thus recycling pantothenic
CC       acid (vitamin B5) and releasing cysteamine.
CC       {ECO:0000269|PubMed:10567687, ECO:0000269|PubMed:11491533,
CC       ECO:0000269|PubMed:25478849}.
CC   -!- CATALYTIC ACTIVITY: (R)-pantetheine + H(2)O = (R)-pantothenate +
CC       2-aminoethanethiol. {ECO:0000269|PubMed:11491533,
CC       ECO:0000269|PubMed:25478849}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:25478849}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:11491533};
CC       Lipid-anchor, GPI-anchor {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in
CC       spleen, kidney and blood. Overexpressed in lesional psoriatic
CC       skin. {ECO:0000269|PubMed:19322213}.
CC   -!- INDUCTION: By Th17/Th1 type cytokines, but not by Th2-type.
CC       {ECO:0000269|PubMed:19322213}.
CC   -!- SIMILARITY: Belongs to the carbon-nitrogen hydrolase superfamily.
CC       BTD/VNN family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/vnn1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132099; CAA10568.1; -; mRNA.
DR   EMBL; U39664; AAF21453.1; -; mRNA.
DR   EMBL; AK290425; BAF83114.1; -; mRNA.
DR   EMBL; DQ100297; AAY88742.1; -; Genomic_DNA.
DR   EMBL; AL032821; CAB40075.1; -; Genomic_DNA.
DR   EMBL; BC096265; AAH96265.1; -; mRNA.
DR   EMBL; BC096266; AAH96266.1; -; mRNA.
DR   EMBL; BC096267; AAH96267.1; -; mRNA.
DR   EMBL; BC096268; AAH96268.1; -; mRNA.
DR   CCDS; CCDS5159.1; -.
DR   RefSeq; NP_004657.2; NM_004666.2.
DR   UniGene; Hs.12114; -.
DR   UniGene; Hs.720659; -.
DR   PDB; 4CYF; X-ray; 2.25 A; A/B=22-513.
DR   PDB; 4CYG; X-ray; 2.30 A; A/B=22-513.
DR   PDB; 4CYY; X-ray; 2.89 A; A=27-513.
DR   PDBsum; 4CYF; -.
DR   PDBsum; 4CYG; -.
DR   PDBsum; 4CYY; -.
DR   ProteinModelPortal; O95497; -.
DR   SMR; O95497; -.
DR   BioGrid; 114395; 1.
DR   STRING; 9606.ENSP00000356905; -.
DR   iPTMnet; O95497; -.
DR   PhosphoSitePlus; O95497; -.
DR   BioMuta; VNN1; -.
DR   PaxDb; O95497; -.
DR   PeptideAtlas; O95497; -.
DR   PRIDE; O95497; -.
DR   Ensembl; ENST00000367928; ENSP00000356905; ENSG00000112299.
DR   GeneID; 8876; -.
DR   KEGG; hsa:8876; -.
DR   UCSC; uc003qdo.4; human.
DR   CTD; 8876; -.
DR   DisGeNET; 8876; -.
DR   GeneCards; VNN1; -.
DR   H-InvDB; HIX0022602; -.
DR   HGNC; HGNC:12705; VNN1.
DR   HPA; HPA064145; -.
DR   MIM; 603570; gene.
DR   neXtProt; NX_O95497; -.
DR   OpenTargets; ENSG00000112299; -.
DR   PharmGKB; PA37321; -.
DR   eggNOG; KOG0806; Eukaryota.
DR   eggNOG; COG0388; LUCA.
DR   GeneTree; ENSGT00390000013823; -.
DR   HOVERGEN; HBG003996; -.
DR   InParanoid; O95497; -.
DR   KO; K08069; -.
DR   OMA; RYYLQIC; -.
DR   OrthoDB; EOG091G04QD; -.
DR   PhylomeDB; O95497; -.
DR   TreeFam; TF323645; -.
DR   BRENDA; 3.5.1.92; 2681.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   Reactome; R-HSA-199220; Vitamin B5 (pantothenate) metabolism.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   GeneWiki; VNN1; -.
DR   GenomeRNAi; 8876; -.
DR   PRO; PR:O95497; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112299; -.
DR   CleanEx; HS_VNN1; -.
DR   Genevisible; O95497; HS.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0017159; F:pantetheine hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0002526; P:acute inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0006501; P:C-terminal protein lipidation; TAS:Reactome.
DR   GO; GO:0002544; P:chronic inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; ISS:BHF-UCL.
DR   GO; GO:0045087; P:innate immune response; ISS:BHF-UCL.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:ProtInc.
DR   GO; GO:1902176; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0015939; P:pantothenate metabolic process; IDA:UniProtKB.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:BHF-UCL.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; ISS:BHF-UCL.
DR   Gene3D; 3.60.110.10; -; 1.
DR   InterPro; IPR012101; Biotinidase_euk.
DR   InterPro; IPR003010; C-N_Hydrolase.
DR   PANTHER; PTHR10609; PTHR10609; 1.
DR   Pfam; PF00795; CN_hydrolase; 1.
DR   PIRSF; PIRSF011861; Biotinidase; 1.
DR   SUPFAM; SSF56317; SSF56317; 1.
DR   PROSITE; PS50263; CN_HYDROLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Glycoprotein;
KW   GPI-anchor; Hydrolase; Lipoprotein; Membrane; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    491       Pantetheinase.
FT                                /FTId=PRO_0000019712.
FT   PROPEP      492    513       Removed in mature form. {ECO:0000255}.
FT                                /FTId=PRO_0000019713.
FT   DOMAIN       25    328       CN hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054}.
FT   ACT_SITE     79     79       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054,
FT                                ECO:0000305|PubMed:25478849}.
FT   ACT_SITE    178    178       Proton donor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054,
FT                                ECO:0000305|PubMed:25478849}.
FT   ACT_SITE    211    211       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00054,
FT                                ECO:0000269|PubMed:25478849}.
FT   LIPID       491    491       GPI-anchor amidated glycine.
FT                                {ECO:0000255}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4CYF,
FT                                ECO:0000244|PDB:4CYG,
FT                                ECO:0000244|PDB:4CYY,
FT                                ECO:0000269|PubMed:15084671}.
FT   CARBOHYD    130    130       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4CYF,
FT                                ECO:0000244|PDB:4CYG,
FT                                ECO:0000244|PDB:4CYY,
FT                                ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4CYY, ECO:0000255}.
FT   CARBOHYD    283    283       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    315    315       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4CYF,
FT                                ECO:0000244|PDB:4CYG,
FT                                ECO:0000244|PDB:4CYY,
FT                                ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:4CYF,
FT                                ECO:0000244|PDB:4CYG,
FT                                ECO:0000244|PDB:4CYY,
FT                                ECO:0000269|PubMed:15084671,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   VARIANT      26     26       T -> I (in dbSNP:rs2294757).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9790769,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023529.
FT   VARIANT      63     63       A -> T. {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023967.
FT   VARIANT     131    131       N -> S (in dbSNP:rs2272996).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023968.
FT   VARIANT     136    136       V -> L (in dbSNP:rs45610032).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023969.
FT   VARIANT     146    146       D -> N (in dbSNP:rs45624336).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023970.
FT   VARIANT     296    296       E -> D (in dbSNP:rs45523444).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023971.
FT   VARIANT     325    325       A -> E (in dbSNP:rs34535050).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023972.
FT   VARIANT     336    336       T -> A (in dbSNP:rs45562238).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023973.
FT   VARIANT     373    373       I -> T (in dbSNP:rs35938565).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_023974.
FT   MUTAGEN      79     79       E->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25478849}.
FT   MUTAGEN     178    178       K->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25478849}.
FT   CONFLICT    101    101       D -> N (in Ref. 6; AAH96268).
FT                                {ECO:0000305}.
FT   CONFLICT    113    113       N -> I (in Ref. 4; AAY88742).
FT                                {ECO:0000305}.
FT   CONFLICT    423    423       E -> D (in Ref. 2; AAF21453).
FT                                {ECO:0000305}.
FT   STRAND       24     32       {ECO:0000244|PDB:4CYF}.
FT   HELIX        46     68       {ECO:0000244|PDB:4CYF}.
FT   TURN         69     71       {ECO:0000244|PDB:4CYF}.
FT   STRAND       73     76       {ECO:0000244|PDB:4CYF}.
FT   TURN         79     83       {ECO:0000244|PDB:4CYF}.
FT   HELIX        89     92       {ECO:0000244|PDB:4CYF}.
FT   HELIX        93     95       {ECO:0000244|PDB:4CYF}.
FT   HELIX       102    104       {ECO:0000244|PDB:4CYF}.
FT   TURN        108    110       {ECO:0000244|PDB:4CYF}.
FT   TURN        112    115       {ECO:0000244|PDB:4CYF}.
FT   HELIX       119    130       {ECO:0000244|PDB:4CYF}.
FT   STRAND      134    144       {ECO:0000244|PDB:4CYF}.
FT   STRAND      156    166       {ECO:0000244|PDB:4CYF}.
FT   STRAND      172    177       {ECO:0000244|PDB:4CYF}.
FT   STRAND      198    201       {ECO:0000244|PDB:4CYF}.
FT   STRAND      204    208       {ECO:0000244|PDB:4CYF}.
FT   HELIX       211    215       {ECO:0000244|PDB:4CYF}.
FT   TURN        217    219       {ECO:0000244|PDB:4CYY}.
FT   HELIX       220    225       {ECO:0000244|PDB:4CYF}.
FT   STRAND      230    236       {ECO:0000244|PDB:4CYF}.
FT   TURN        242    244       {ECO:0000244|PDB:4CYF}.
FT   HELIX       247    258       {ECO:0000244|PDB:4CYF}.
FT   STRAND      261    267       {ECO:0000244|PDB:4CYF}.
FT   HELIX       270    272       {ECO:0000244|PDB:4CYF}.
FT   STRAND      277    280       {ECO:0000244|PDB:4CYF}.
FT   STRAND      282    289       {ECO:0000244|PDB:4CYF}.
FT   STRAND      298    307       {ECO:0000244|PDB:4CYF}.
FT   HELIX       318    321       {ECO:0000244|PDB:4CYF}.
FT   STRAND      332    337       {ECO:0000244|PDB:4CYF}.
FT   STRAND      340    346       {ECO:0000244|PDB:4CYF}.
FT   STRAND      349    358       {ECO:0000244|PDB:4CYF}.
FT   STRAND      361    371       {ECO:0000244|PDB:4CYF}.
FT   STRAND      378    387       {ECO:0000244|PDB:4CYF}.
FT   STRAND      393    402       {ECO:0000244|PDB:4CYF}.
FT   STRAND      404    407       {ECO:0000244|PDB:4CYF}.
FT   HELIX       408    410       {ECO:0000244|PDB:4CYF}.
FT   STRAND      422    429       {ECO:0000244|PDB:4CYF}.
FT   STRAND      436    442       {ECO:0000244|PDB:4CYF}.
FT   HELIX       443    445       {ECO:0000244|PDB:4CYF}.
FT   STRAND      451    454       {ECO:0000244|PDB:4CYF}.
FT   STRAND      460    465       {ECO:0000244|PDB:4CYF}.
FT   STRAND      470    478       {ECO:0000244|PDB:4CYF}.
FT   HELIX       480    482       {ECO:0000244|PDB:4CYF}.
SQ   SEQUENCE   513 AA;  57012 MW;  018D2417C12E403F CRC64;
     MTTQLPAYVA ILLFYVSRAS CQDTFTAAVY EHAAILPNAT LTPVSREEAL ALMNRNLDIL
     EGAITSAADQ GAHIIVTPED AIYGWNFNRD SLYPYLEDIP DPEVNWIPCN NRNRFGQTPV
     QERLSCLAKN NSIYVVANIG DKKPCDTSDP QCPPDGRYQY NTDVVFDSQG KLVARYHKQN
     LFMGENQFNV PKEPEIVTFN TTFGSFGIFT CFDILFHDPA VTLVKDFHVD TIVFPTAWMN
     VLPHLSAVEF HSAWAMGMRV NFLASNIHYP SKKMTGSGIY APNSSRAFHY DMKTEEGKLL
     LSQLDSHPSH SAVVNWTSYA SSIEALSSGN KEFKGTVFFD EFTFVKLTGV AGNYTVCQKD
     LCCHLSYKMS ENIPNEVYAL GAFDGLHTVE GRYYLQICTL LKCKTTNLNT CGDSAETAST
     RFEMFSLSGT FGTQYVFPEV LLSENQLAPG EFQVSTDGRL FSLKPTSGPV LTVTLFGRLY
     EKDWASNASS GLTAQARIIM LIVIAPIVCS LSW
//
